Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2000 Feb;91(2):204–212. doi: 10.1111/j.1349-7006.2000.tb00933.x

Germ‐line Mutation Analysis in Patients with von Hippel‐Lindau Disease in Japan: An Extended Study of 77 Families

Minoru Yoshida 1, Shingo Ashida 2, Keiichi Kondo 1, Kazuki Kobayashi 1, Hiroshi Kanno 3, Nobuo Shinohara 4, Nobuyuki Shitara 5, Takeshi Kishida 1, Satoshi Kawakami 1, Masaya Baba 1, Isao Yamamoto 2, Masahiko Hosaka 1, Taro Shuin 2, Masahiro Yao 1,✉
PMCID: PMC5926327  PMID: 10761708

Abstract

We have previously reported on the analysis of germ‐line mutations in Japanese von Hippel‐Lindau disease (VHL) patients and found mutations in 26 families. We have now extended these studies to include an additional 41 VHL families. Germ‐line mutation of the VHL, gene was screened by DNA‐SSCP, direct sequencing, and Southern blot analysis. To summarize all of the data we have studied in this and our previous report, germ‐line mutations have been detected in 55 of 77 (73%) (type 1: 41 / 62 (66%) and type 2: 14/15 (93%)) families. We found similarities in the nature of germ‐line mutations including mutational incidence, location, and DNA substitution patterns between Japanese and Western VHL. These similarities may reflect the predominance of endogenous mutational processes. We also found several interesting characteristics in Japanese VHL. Twenty of 41 (49%) intragenic mutations were unique and not reported in the Western VHL. Four mutations (Arg113Stop, Gln132Stop, Leu158Val, and Cys162Tyr) previously characterized as type 1 mutations were identified in the type 2 (with pheochromocytoma) Japanese families. Genotype‐phenotype correlation study suggested non‐missense mutations predicted to result in the loss of VHL function were associated with the occurrence of renal cell carcinoma, as in sporadic tumors. Our data add to the diversity of VHL germ‐line mutations and provide a better understanding of VHL disease in terms of both clinical management and molecular pathogenesis.

Keywords: VHL gene, Tumor suppressor, Mutation, Germ‐line, Polymorphism

Full Text

The Full Text of this article is available as a PDF (206.0 KB).

REFERENCES

  • 1. ) Glenn , G. M. , Choyke , P. L. , Zbar , B. and Linehan , W. M.Von Hippel‐Lindau disease . Probl. Uol. , 4 , 312 – 330 ( 1990. ). [Google Scholar]
  • 2. ) Latif , F. , Tory , K. , Gnarra , J. , Yao , M. , Duh , F. M. , Orcutt , M. L. , Stackhouse , T. , Kuzmin , I. , Modi , W. , Geil , L. , Schmidt , L. , Zhou , F. , Li , H. , Wei , M. H. , Chen , F. , Glenn , G. , Choyke , P. , Walther , M. M. , Weng , Y. , Duan , D. R. , Dean , M. , Glavac , D. , Richards , F. M. , Crossey , P. A. , Ferguson‐Smith , M. A. , Le Paslier , D. , Chumakov , I. , Cohen , D. , Chinault , A. C. , Maher , E. R. , Linehan , W. M. , Zbar , B. and Lerman , M. I.Identification of the von Hippel‐Lindau disease tumor suppressor gene . Science , 260 , 1317 – 1320 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Gnarra , J. R. , Tory , K. , Weng , Y. , Schmidt , L. , Wei , M. H. , Li , H. , Latif , F. , Liu , S. , Chen , F. , Duh , F. M. , Lubensky , I. , Duan , D. R. , Florence , C. , Pozzatti , R. , Walther , M. M. , Bander , N. H. , Grossman , H. B. , Brauch , H. , Pomer , S. , Brooks , J. D. , Isaacs , W. B. , Lerman , M. I. , Zbar , B. and Linehan , W. M.Mutations of the VHL tumour suppressor gene in renal carcinoma . Nat. Genet. , 7 , 85 – 90 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Shuin , T. , Kondo , K. , Torigoe , S. , Kishida , T. , Kubota , Y. , Hosaka , M. , Nagashima , Y. , Kitamura , H. , Latif , F. , Zbar , B. , Lerman , M. I. and Yao , M.Frequent somatic mutations and loss of heterozygosity of the von Hippel‐Lindau tumor suppressor gene in primary human renal cell carcinomas . Cancer Res. , 54 , 2852 – 2855 ( 1994. ). [PubMed] [Google Scholar]
  • 5. ) Kanno , H. , Kondo , K. , Ito , S. , Yamamoto , I. , Fujii , S. , Torigoe , S. , Sakai , N. , Hosaka , M. , Shuin , T. and Yao , M.Somatic mutations of the von Hippel‐Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas . Cancer Res. , 54 , 4845 – 4847 ( 1994. ). [PubMed] [Google Scholar]
  • 6. ) Gilcrease , M. Z. , Schmidt , L. , Zbar , B. , Truong , L. , Rutledge , M. and Wheeler , T. M.Somatic von Hippel‐Lindau mutation in clear cell papillary cystadenoma of the epididymis . Hum. Pathol. , 26 , 1341 – 1346 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Vortmeyer , A. O. , Lubensky , I. A. , Fogt , F. , Linehan , W. M. , Khettry , U. and Zhuang , Z.Allelic deletion and mutation of the von Hippel‐Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas . Am. J. Pathol. , 151 , 951 – 956 ( 1997. ). [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Zbar , B. , Kishida , T. , Chen , F. , Schmidt , L. , Maher , E. R. , Richards , F. M. , Crossey , P. A. , Webster , A. R. , Affara , N. A. , Ferguson‐Smith , M. A. , Brauch , H. , Glavac , D. , Neumann , H. P. , Tisherman , S. , Mulvihill , J. J. , Gross , D. J. , Shuin , T. , Whaley , J. , Seizinger , B. , Kley , N. , Olschwang , S. , Boisson , C. , Richard , S. , Lips , C. H. M. , Linehan , W. M. and Lerman , M.Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan . Hum. Mutat. , 8 , 348 – 357 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Prowse , A. H. , Webster , A. R. , Richards , F. M. , Richard , S. , Olschwang , S. , Resche , F. , Affara , N. A. and Maher , E. R.Somatic inactivation of the VHL gene in Von Hippel‐Lindau disease tumors . Am. J. Hum. Genet. , 60 , 765 – 771 ( 1997. ). [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Knudson , A. G.VHL gene mutation and clear‐cell renal carcinomas . Cancer J. Sci. Am. , 1 , 180 ( 1995. ). [PubMed] [Google Scholar]
  • 11. ) Duan , D. R. , Pause , A. , Burgess , W. H. , Aso , T. , Chen , D. Y. T. , Garrett , K. P. , Conaway , R. C. , Conaway , J. W. , Linehan , W. M. and Klausner , R. D.Inhibition of transcription elongation by the VHL tumor suppressor . Science , 269 , 1402 – 1406 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Kibel , A. , Iliopoulos , O. , Decaprio , J. A. and Kaelin , W. G. , Jr.Binding of the von Hippel‐Lindau tumor suppressor protein to elongin B and C . Science , 269 , 1444 – 1446 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Kamura , T. , Koepp , D. M. , Conrad , M. N. , Skowyra , D. , Moreland , R. J. , Iliopoulos , O. , Lane , W. S. , Kaelin , W. G. , Jr. , Elledge , S. J. , Conaway , R. C. , Harper , J. W. and Conaway , Rbxl J. W. , a component of the VHL tumor suppressor complex and SCF ubiquitin ligase . Science , 284 , 657 – 661 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Tsuchiya , H. , Iseda , T. and Hino , O.Identification of a novel protein (VBP‐1) binding to the von Hippel‐Lindau (VHL) tumor suppressor gene product . Cancer Res. , 56 , 2881 – 2885 ( 1996. ). [PubMed] [Google Scholar]
  • 15. ) Mukhopadhyay , D. , Knebelmann , B. , Cohen , H. T. , Ananth , S. and Sukhatme , V. P.The von Hippel‐Lindau tumor suppressor gene product interacts with Spl to repress vascular endothelial growth factor promoter activity . Mol. Cell. Biol. , 17 , 5629 – 5639 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Ohh , M. , Yauch , R. L. , Lonergan , K. M. , Whaley , J. M. , Stemmer‐Rachamimov , A. O. , Louis , D. N. , Gavin , B. J. , Kley , N. , Kaelin , W. G. , Jr. and Iliopoulos , O.The von Hippel‐Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix . Mol. Cell , 1 , 959 – 968 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Maxwell , P. H. , Wiesener , M. S. , Chang , G. W. , Clifford , S. C. , Vaux , E. C. , Cockman , M. E. , Wykoff , C. C. , Pugh , C. W. , Maher , E. R. and Ratcliffe , P. J.The tumour suppressor protein VHL targets hypoxia‐inducible factors for oxygen‐dependent proteolysis . Nature , 399 , 271 – 275 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Cohen , H. T. , Zhou , M. , Welsh , A. M. , Zarghamee , S. , Scholz , H. , Mukhopadhyay , D. , Kishida , T. , Zbar , B. , Knebelmann , B. and Sukhatme , V. P.An important von Hippel‐Lindau tumor suppressor domain mediates Spl‐binding and self‐association . Biochem. Biophys. Res. Commun. , 266 , 43 – 50 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Zbar , B. , Kaelin , W. , Maher , E. and Richard , S.Third International Meeting on von Hippel‐Lindau disease . Cancer Res. , 59 , 2251 – 2253 ( 1999. ). [PubMed] [Google Scholar]
  • 20. ) Clinical Research Group for VHL in Japan . Germline mutations in the von Hippel‐Lindau disease (VHL) gene in Japanese VHL . Hum. Mol. Genet. , 4 , 2233 – 2237 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Maniatis , T. , Fritsch , E. F. and Sambrook , J. “ Molecular Cloning: a Laboratory Manual” ( 1989. ). Cold Spring Harbor Press; , Cold Spring Harbor , NY . [Google Scholar]
  • 22. ) Foster , K. , Prowse , A. , van den Berg , A. , Fleming , S. , Hulsbeek , M. M. , Crossey , P. A. , Richards , F. M. , Cairns , P. , Affara , N. A. , Ferguson‐Smith , M. A. , Buys , C. H. C. M. and Maher , E. R.Somatic mutations of the von Hippel‐Lindau disease tumour suppressor gene in non‐familial clear cell renal carcinoma . Hum. Mol. Genet. , 3 , 2169 – 2173 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Gao , J. , Naglich , J. G. , Laidlaw , J. , Whaley , J. M. , Seizinger , B. R. and Kley , N.Cloning and characterization of a mouse gene with homology to the human von Hippel‐Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel‐Lindau disease gene . Cancer Res. , 55 , 743 – 747 ( 1995. ). [PubMed] [Google Scholar]
  • 24. ) Duan , D. R. , Humphrey , J. S. , Chen , D. Y. , Weng , Y. , Sukegawa , J. , Lee , S. , Gnarra , J. R. , Linehan , M. W. and Klausner , R. D.Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations . Proc. Natl. Acad. Sci. USA , 92 , 6459 – 6463 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Iliopoulos , O. , Ohh , M. and Kaelin , W. G. , Jr.pVHL19 is a biologically active product of the von Hippel‐Lindau gene arising from internal translation initiation . Proc. Natl. Acad. Sci. USA , 95 , 11661 – 11666 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Schoenfeld , A. , Davidowitz , E. J. and Burk , R. D.A second major native von Hippel‐Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor . Proc. Natl. Acad. Sci. USA , 95 , 8817 – 8822 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Stebbins , C. E. , Kaelin , W. G. , Jr. and Pavletich , N. P.Structure of the VHL‐elongin C‐elongin B complex: implications for VHL tumor suppressor function . Science , 284 , 455 – 461 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Okuda , H. , Hirai , S. , Takaki , Y. , Kamata , M. , Baba , M. , Sakai , N. , Kishida , T. , Yao , M. , Ohno , S. and Shuin , T.Direct interaction of the β‐domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes . Biochem. Biophys. Res. Commun. , 263 , 491 – 497 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Kishida , T. , Stackhouse , T. M. , Chen , F. , Lerman , M. I. , and Zbar , B.Cellular proteins that bind the von Hippel‐Lindau disease gene product: mapping the binding domains and the effect of missense mutations . Cancer Res. , 55 , 4544 – 4548 ( 1995. ). [PubMed] [Google Scholar]
  • 30. ) Lonergan , K. M. , Iliopoulos , O. , Ohh , M. , Kamura , T. , Conaway , R. C. , Conaway , J. W. , and Kaelin , W. G. , Jr.Regulation of hypoxia‐inducible mRNAs by the von Hippel‐Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2 . Mol. Cell. Biol. , 18 , 732 – 741 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) Kanno , H. , Shuin , T. , Kondo , K. , Ito , S. , Hosaka , M. , Torigoe , S. , Fujii , S. , Tanaka , Y. , Yamamoto , I. , Kim , I. and Yao , M.Molecular genetic diagnosis of von Hippel‐Lindau disease: analysis of five Japanese families . Jpn. J. Cancer Res. , 87 , 423 – 428 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Stolle , C. , Glenn , G. , Zbar , B. , Humphrey , J. S. , Choyke , P. , Walther , M. , Pack , S. , Hurley , K. , Andrey , C. , Klausner , R. and Linehan , W. M.Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene . Hum. Mutat. , 12 , 417 – 423 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Suzuki , D. T. , Griffiths , A. F. J. , Miller , J. H. and Lewontin , R. C.“An Introduction to Genetic Analysis ,” 3rd Ed. , pp. 333 – 353 ( 1986. ). W. H. Freeman; , New York . [Google Scholar]
  • 34. ) Sommer , S. S.Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene . FASEB J. , 6 , 2767 – 2774 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Kinzler , K. W. and Vogelstein , V.Lessons from hereditary colorectal cancer . Cell , 87 , 159 – 170 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Eng , C. , Crossey , P. A. , Mulligan , L. M. , Healey , C. S. , Houghton , C. , Prowse , A. , Chew , S. L. , Dahia , P. L. , O'Riordan , J. L. , Toledo , S. P. , Smith , D. P. , Maher , E. R. and Ponder , B. A. J.Mutations in the RET proto‐oncogene and the von Hippel‐Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas . J. Med. Genet. , 32 , 934 – 937 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES